Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Tirzepatide

SURMOUNT-CN

Eli Lilly · Phase 3 · Completed · Enrollment 210

NCT05024032

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
10 Milligrams (mg) Tirzepatiden/rn/rn/rn/rn/r
15 mg Tirzepatide23 participants14 participants29 participantsn/r0
Placebo4 participants3 participants6 participantsn/r0
10 mg Tirzepatide21 participants8 participants28 participantsn/r0

A count stays a count. This page does not turn a count into a percent.